Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database
| Autor: | Raymond Khargi, Danielle J. Gordon, Kyle P. Michelson, Nicholas R. Suss, Thomas F. Monaghan, Tashzna Jones, Matthew T. Smith, Dylan T. Wolff, Andrew G. Winer, Hyezo Kwun, Fenizia Maffucci |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
kidney Medicine (General) Databases Factual NCDB penile computer.software_genre White People Article 03 medical and health sciences Prostate cancer 0302 clinical medicine access R5-920 Testicular Neoplasms Medicine Penile cancer Humans race bladder Testicular cancer 030505 public health Bladder cancer prostate Database business.industry Incidence Cancer General Medicine medicine.disease Primary tumor testicular USCS Race Factors disparity 030220 oncology & carcinogenesis Pacific islanders Female 0305 other medical science business computer Kidney cancer |
| Zdroj: | Medicina, Vol 57, Iss 671, p 671 (2021) Medicina Volume 57 Issue 7 |
| ISSN: | 1648-9144 |
| Popis: | Background and Objectives: The National Cancer Database (NCDB) captures nearly 70% of all new cancer diagnoses in the United States, but there exists significant variation in this capture rate based on primary tumor location and other patient demographic factors. Prostate cancer has the lowest coverage rate of all major cancers, and other genitourinary malignancies likewise fall below the average NCDB case coverage rate. We aimed to explore NCDB coverage rates for patients with genitourinary cancers as a function of race. Materials and Methods: We compared the incidence of cancer cases in the NCDB with contemporary United States Cancer Statistics data. Results: Across all malignancies, American Indian/Alaskan Natives subjects demonstrated the lowest capture rates, and Asian/Pacific Islander subjects exhibited the second-lowest capture rates. Between White and Black subjects, capture rates were significantly higher for White subjects overall and for prostate cancer and kidney cancer in White males, but significantly higher for bladder cancer in Black versus White females. No significant differences were observed in coverage rates for kidney cancer in females, bladder cancer in males, penile cancer, or testicular cancer in White versus Black patients. Conclusions: Differential access to Commission on Cancer-accredited treatment facilities for racial minorities with genitourinary cancer constitutes a unique avenue for health equity research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|